These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27103022)

  • 41. Preclinical Evaluation and Quantification of 18F-FPEB as a Radioligand for PET Imaging of the Metabotropic Glutamate Receptor 5.
    de Laat B; Leurquin-Sterk G; Celen S; Bormans G; Koole M; Van Laere K; Casteels C
    J Nucl Med; 2015 Dec; 56(12):1954-9. PubMed ID: 26405172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors.
    Barret O; Hannestad J; Vala C; Alagille D; Tavares A; Laruelle M; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2015 Apr; 56(4):586-91. PubMed ID: 25698783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.
    Tian M; Ogawa K; Wendt R; Mukhopadhyay U; Balatoni J; Fukumitsu N; Uthamanthil R; Borne A; Brammer D; Jackson J; Mawlawi O; Yang B; Alauddin MM; Gelovani JG
    J Nucl Med; 2011 Jun; 52(6):934-41. PubMed ID: 21571803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [
    Zheng C; Holden D; Zheng MQ; Pracitto R; Wilcox KC; Lindemann M; Felchner Z; Zhang L; Tong J; Fowles K; Finnema SJ; Nabulsi N; Carson RE; Huang Y; Cai Z
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1482-1496. PubMed ID: 34761284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
    Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
    Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
    J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
    Ahmad R; Postnov A; Bormans G; Versijpt J; Vandenbulcke M; Van Laere K
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2219-2227. PubMed ID: 27488857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
    Le Foll B; Chefer SI; Kimes AS; Shumway D; Goldberg SR; Stein EA; Mukhin AG
    J Nucl Med; 2007 Sep; 48(9):1492-500. PubMed ID: 17704243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic evaluation of [
    Kramer V; Juri C; Riss PJ; Pruzzo R; Soza-Ried C; Flores J; Hurtado A; Rösch F; Chana-Cuevas P; Amaral H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1927-1937. PubMed ID: 31788709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses.
    Petrou M; Frey KA; Kilbourn MR; Scott PJ; Raffel DM; Bohnen NI; Müller ML; Albin RL; Koeppe RA
    J Nucl Med; 2014 Mar; 55(3):396-404. PubMed ID: 24481024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the novel GlyT1 PET tracer [18F]MK-6577 in humans.
    Joshi AD; Sanabria-Bohórquez SM; Bormans G; Koole M; De Hoon J; Van Hecken A; Depre M; De Lepeleire I; Van Laere K; Sur C; Hamill TG
    Synapse; 2015 Jan; 69(1):33-40. PubMed ID: 25196464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical validation of the novel HDAC6 radiotracer [
    Koole M; Van Weehaeghe D; Serdons K; Herbots M; Cawthorne C; Celen S; Schroeder FA; Hooker JM; Bormans G; de Hoon J; Kranz JE; Van Laere K; Gilbert TM
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):596-611. PubMed ID: 32638097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PET imaging of α
    Hillmer AT; Li S; Zheng MQ; Scheunemann M; Lin SF; Nabulsi N; Holden D; Pracitto R; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Esterlis I; Cosgrove KP; Brust P; Carson RE; Huang Y
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1042-1050. PubMed ID: 28120003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization in nonhuman primates of (R)-[
    Zheng M; Ahmed H; Smart K; Xu Y; Holden D; Kapinos M; Felchner Z; Haider A; Tamagnan G; Carson RE; Huang Y; Ametamey SM
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2153-2162. PubMed ID: 35107627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification of aromatase binding in the female human brain using [
    Jonasson M; Nordeman P; Eriksson J; Wilking H; Wikström J; Takahashi K; Niwa T; Hosoya T; Watanabe Y; Antoni G; Sundström Poromaa I; Lubberink M; Comasco E
    J Neurosci Res; 2020 Nov; 98(11):2208-2218. PubMed ID: 32761874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety, Dosimetry, and Tumor Detection Ability of
    Skovgaard D; Persson M; Brandt-Larsen M; Christensen C; Madsen J; Klausen TL; Holm S; Andersen FL; Loft A; Berthelsen AK; Pappot H; Brasso K; Kroman N; Højgaard L; Kjaer A
    J Nucl Med; 2017 Mar; 58(3):379-386. PubMed ID: 27609788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First in-human PET study and kinetic evaluation of [
    Bhatt S; Nabulsi NB; Li S; Cai Z; Matuskey D; Bini J; Najafzadeh S; Kapinos M; Ropchan JR; Carson RE; Cosgrove KP; Huang Y; Hillmer AT
    J Cereb Blood Flow Metab; 2020 Apr; 40(4):695-704. PubMed ID: 30895878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
    Leurquin-Sterk G; Celen S; Van Laere K; Koole M; Bormans G; Langlois X; Van Hecken A; Te Riele P; Alcázar J; Verbruggen A; de Hoon J; Andrés JI; Schmidt ME
    J Nucl Med; 2017 Jan; 58(1):110-116. PubMed ID: 27469358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.